Texas 2021 - 87th Regular

Texas House Bill HB3233 Compare Versions

OldNewDifferences
1-By: Moody, Stephenson, Coleman, Minjarez, H.B. No. 3233
2- J. Johnson of Harris
1+87R7060 KKR-F
2+ By: Moody H.B. No. 3233
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to the establishment by certain counties and hospital
88 districts of disease control pilot programs to reduce the risk of
99 certain infectious and communicable diseases; authorizing fees.
1010 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
11- SECTION 1. This Act shall be cited as the Honorable Ruth
12- Jones McClendon Act.
13- SECTION 2. The legislature finds that because drug abuse
11+ SECTION 1. The legislature finds that because drug abuse
1412 has been a tragedy for many Texas families, it is imperative for
1513 individuals addicted to drugs to receive education about and
1614 treatment for addiction. Cooperation with community-based and
1715 faith-based organizations creates a network of support for Texas
1816 families and the opportunity to intervene in drug addiction.
1917 Members of community-based and faith-based organizations have a
2018 strong desire to compassionately preserve lives and help those
2119 stricken with disease and drug addiction.
2220 Allowing the operation of disease control pilot programs will
2321 reduce the transmission of blood-borne diseases, including
2422 HIV/AIDS, hepatitis B, and hepatitis C, and provide program
2523 participants with referrals to appropriate health and social
2624 services. A pilot program established under this Act may provide
2725 necessary access to primary health care, ensure safe and sterile
2826 disposal of used syringes and needles, and protect the public
2927 health. Pilot program goals may include reduced rates of
3028 intravenous drug use and a reduced number of injuries to innocent
3129 victims, first responders, and law enforcement caused by needle
3230 sticks from improperly disposed needles. Additionally, it is the
3331 intent of the legislature for a pilot program to increase access to
3432 substance abuse treatment services, increase the likelihood of
3533 successful treatments for addiction, and protect the public health
3634 and safety.
37- SECTION 3. Section 531.0972, Government Code, is amended to
35+ SECTION 2. Section 531.0972, Government Code, is amended to
3836 read as follows:
3937 Sec. 531.0972. PILOT PROGRAM TO PREVENT [THE] SPREAD OF
4038 CERTAIN INFECTIOUS AND [OR] COMMUNICABLE DISEASES. The commission
4139 may provide guidance to the counties and hospital districts in
4240 those counties that establish [local health authority of Bexar
4341 County in establishing] a disease control pilot program under
4442 Subchapter K, Chapter 81, Health and Safety Code, [funded by the
4543 county] to prevent the spread of HIV, hepatitis B, hepatitis C, and
4644 other infectious and communicable diseases. The program may
4745 include a disease control outreach program that provides for the
4846 anonymous exchange of used hypodermic needles and syringes.
49- SECTION 4. Chapter 81, Health and Safety Code, is amended by
47+ SECTION 3. Chapter 81, Health and Safety Code, is amended by
5048 adding Subchapter K to read as follows:
5149 SUBCHAPTER K. PILOT PROGRAMS TO REDUCE RISK OF CERTAIN INFECTIOUS
5250 AND COMMUNICABLE DISEASES
5351 Sec. 81.501. APPLICABILITY OF SUBCHAPTER. This subchapter
5452 applies only to Bexar, Dallas, El Paso, Harris, Nueces, Travis, and
5553 Webb Counties and hospital districts in those counties.
5654 Sec. 81.502. DISEASE CONTROL PILOT PROGRAM. (a) A county
5755 or hospital district may establish a disease control pilot program
5856 under this subchapter to prevent the spread of infectious and
5957 communicable diseases, including HIV, hepatitis B, and hepatitis C.
6058 The pilot program may include disease control outreach programs
6159 that:
6260 (1) provide for the anonymous exchange of used
6361 hypodermic needles and syringes for an equal number of new
6462 hypodermic needles and syringes;
6563 (2) offer education on the transmission and prevention
6664 of infectious and communicable diseases, including HIV, hepatitis
6765 B, and hepatitis C; and
6866 (3) assist program participants in obtaining health
6967 care and other physical and mental health-related services,
7068 including substance abuse treatment services and blood-borne
7169 disease testing.
7270 (b) A county or hospital district may register an
7371 organization to operate the disease control pilot program and
7472 distribute hypodermic needles and syringes to control the spread of
7573 certain infectious and blood-borne communicable diseases. The
7674 county or hospital district may charge the organization a
7775 registration fee in an amount reasonable and necessary to cover the
7876 costs of registration oversight, including coordination with law
7977 enforcement personnel.
8078 (c) A registered organization may charge a program
8179 participant a fee for each hypodermic needle or syringe used in the
8280 program not to exceed 150 percent of the actual cost to the
8381 organization of the hypodermic needle or syringe.
8482 (d) A registered organization shall annually provide to the
8583 department and the county or hospital district that registered the
8684 organization information on:
8785 (1) the effectiveness of the disease control pilot
8886 program;
8987 (2) the program's impact on reducing the spread of
9088 infectious and communicable diseases, including HIV, hepatitis B,
9189 and hepatitis C; and
9290 (3) the program's effect on injected drug use by
9391 individuals residing within the county or hospital district.
9492 Sec. 81.503. DISTRIBUTION OF NEEDLES AND SYRINGES TO PILOT
9593 PROGRAM. A person licensed as a wholesale drug distributor or
9694 device distributor under Chapter 431 may distribute hypodermic
9795 needles and syringes to a disease control pilot program authorized
9896 by this subchapter.
9997 Sec. 81.504. HANDLING OF NEEDLES AND SYRINGES. An
10098 organization registered as provided by Section 81.502:
10199 (1) shall store hypodermic needles and syringes in a
102100 proper and secure manner and allow only authorized employees or
103101 volunteers of the organization's disease control pilot program to
104102 access the hypodermic needles and syringes;
105103 (2) may include hypodermic needles and syringes in
106104 packaged safe kits made available to program participants through
107105 the program;
108106 (3) may provide hypodermic needles and syringes and
109107 safe kits to program participants only through an authorized
110108 employee or volunteer of the program; and
111109 (4) shall store and dispose of used hypodermic needles
112110 and syringes in accordance with applicable state laws and
113111 administrative rules governing the safe and proper disposal of
114112 medical waste.
115113 Sec. 81.505. FUNDING. Except to the extent specifically
116114 prohibited by law, an organization registered to operate a disease
117115 control pilot program as provided by Section 81.502 may solicit or
118116 accept gifts, grants, or donations to fund the program.
119117 Sec. 81.506. EXPIRATION. This subchapter expires September
120118 1, 2031.
121- SECTION 5. Section 481.125, Health and Safety Code, is
119+ SECTION 4. Section 481.125, Health and Safety Code, is
122120 amended by adding Subsections (g), (h), (i), and (j) to read as
123121 follows:
124122 (g) Subsections (a) and (b) do not apply to a person who
125123 possesses or delivers a hypodermic needle or syringe for a medical
126124 purpose. For the purposes of this subsection, "medical purpose"
127125 includes the exchange of a hypodermic needle or syringe for a used
128126 hypodermic needle or syringe in a disease control pilot program
129127 described by Subchapter K, Chapter 81.
130128 (h) Subsections (a) and (b) do not apply to a person who
131129 possesses or manufactures hypodermic needles or syringes for
132130 delivery to a disease control pilot program described by Subchapter
133131 K, Chapter 81.
134132 (i) Subsections (a) and (b) do not apply to a person who is
135133 an employee, volunteer, duly authorized agent, or program
136134 participant of a disease control pilot program described by
137135 Subchapter K, Chapter 81, and uses, possesses, or delivers a
138136 hypodermic needle or syringe as part of the program.
139137 (j) This subsection and Subsections (g), (h), and (i) expire
140138 September 1, 2031.
141- SECTION 6. The change to Section 481.125, Health and Safety
139+ SECTION 5. The change to Section 481.125, Health and Safety
142140 Code, made by this Act applies only to an offense committed on or
143141 after the effective date of this Act. An offense committed before
144142 the effective date of this Act is governed by the law in effect when
145143 the offense was committed, and the former law is continued in effect
146144 for that purpose. For purposes of this section, an offense is
147145 committed before the effective date of this Act if any element of
148146 the offense occurs before the effective date.
149- SECTION 7. This Act takes effect September 1, 2021.
147+ SECTION 6. This Act takes effect September 1, 2021.